powered by StockChartsAI.com

All Charts and Prices Based on Previous Days Close

Enter Stock Symbol to View AI powered Stock Chart

By accessing this site, you agree we are not liable, whether in contract, tort (including negligence) or otherwise, in respect of any damage, expense or other loss you may suffer arising out of such information or any reliance you may place upon such information from this site.

Natera Inc (NTRA)

Industry: Diagnostics & Research

Natera, Inc, a diagnostics company, develops and commercializes molecular testing services worldwide. Its products include Panorama, a non-invasive prenatal test that screens for chromosomal abnormalities of a fetus, as well as in twin pregnancies; Horizon carrier screening test for individuals and couples determine if they are carriers of genetic variations that cause certain genetic conditions; Vistara single-gene NIPT screens for 25 single-gene disorders that cause severe skeletal, cardiac, and neurological conditions; Spectrum, preimplantation genetic tests for couples undergoing IVF; Anora that analyzes miscarriage tissue from women; Empower, a hereditary cancer screening test; and non-invasive prenatal paternity product, which allows a couple to establish paternity without waiting for the child to be born.

Natera, Inc Website


Institution %: 96.092

YTD Institution change: 6510998


Insiders %: 3.751

Insiders Purchases YTD:

Insiders Sales YTD: 56883

Insiders Net YTD: -56883

Analyst Ratings

Target Price: 71.2

Overall Rating: 4.4

Strong Buys (5): 9

Buys (4): 4

Holds (3): 1

Sells (2): 1

Strong Sells (1): 0


52 Week Hi: 63

52 Week Low: 35.02

Beta: 1.179

50 Day MA: 45.4622

200 Day MA: 50.2214

Earnings / Revenue Trends

Qtr Earnings Growth YOY: 0

Qtr Revenue Growth YOY: 0.274

Forward PE:

Trailing PE: